Mustang Bio, Inc.
Mustang Bio is a clinical-stage company developing CAR-T cell therapies for difficult-to-treat cancers.
10-QNov 5Latest SEC filing
Oct 15Latest story
October 2026
Sign inSign inMustang Bio is a clinical-stage company developing CAR-T cell therapies for difficult-to-treat cancers.